Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis have?
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis has 845 citations in the OpenAlex counts ScholarIQ stores.
When was Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis published?
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis has 2016 year in the ScholarIQ index.
What is the open-access status of Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis?
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis has bronze oa status in the ScholarIQ index.
What is the DOI of Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis?
The DOI for Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis is on the source record.
What is the PMID of Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis?
The PMID for Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis is on the source record.
What is the OpenAlex record for Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis?
The OpenAlex for Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis is on the source record.